SKIN profile · all as-reported value updates
SkinHealth Systems Inc. (SKIN) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Stockholders' equity | 2020 | 5,000,008 | -30,567,000 | -35,567,008 | -116.36% | revised comparative figure | 0001213900-21-016237 0001628280-24-010638 | 5 filed observations examined for this concept and period. |
| Net income | 2020 | -1,111,338 | -29,175,000 | -28,063,662 | -96.19% | revised comparative figure | 0001213900-21-016237 0001818093-23-000006 | 3 filed observations examined for this concept and period. |
| Liabilities | 2020 | 16,865,497 | 252,795,000 | 235,929,503 | +93.33% | revised comparative figure | 0001213900-21-016237 0001818093-22-000046 | 3 filed observations examined for this concept and period. |
| Operating income | 2020 | -1,209,550 | -17,182,000 | -15,972,450 | -92.96% | revised comparative figure | 0001213900-21-016237 0001818093-23-000006 | 3 filed observations examined for this concept and period. |
| Assets | 2020 | 464,001,300 | 222,835,000 | -241,166,300 | -51.98% | revised comparative figure | 0001213900-21-016237 0001818093-22-000046 | 3 filed observations examined for this concept and period. |
| Operating income | 2021 | -36,639,000 | -39,928,000 | -3,289,000 | -8.24% | revised comparative figure | 0001818093-22-000046 0001628280-24-010638 | 3 filed observations examined for this concept and period. |
| Operating income | 2022 | -24,280,000 | -25,841,000 | -1,561,000 | -6.04% | revised comparative figure | 0001818093-23-000006 0001628280-25-012407 | 3 filed observations examined for this concept and period. |
| Stockholders' equity | 2022 | 171,476,000 | 167,053,000 | -4,423,000 | -2.58% | revised comparative figure | 0001818093-23-000006 0001628280-26-017376 | 4 filed observations examined for this concept and period. |
| Gross profit | 2021 | 181,827,000 | 178,538,000 | -3,289,000 | -1.81% | revised comparative figure | 0001818093-22-000046 0001628280-24-010638 | 3 filed observations examined for this concept and period. |
| Stockholders' equity | 2021 | 302,297,000 | 298,034,000 | -4,263,000 | -1.41% | revised comparative figure | 0001818093-22-000046 0001628280-25-012407 | 4 filed observations examined for this concept and period. |